Annals of the New York Academy of Sciences

Cover image for Vol. 1182 Cytokine Therapies: Novel Approaches for Clinical Indications

December 2009

Volume 1182 Cytokine Therapies: Novel Approaches for Clinical Indications

Pages 1–160

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents (pages 1–13)

      Raymond P. Donnelly, Howard A. Young and Amy S. Rosenberg

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05382.x

    2. Pharmacologic Administration of Interleukin-2 : Inducing a Systemic Autophagic Syndrome? (pages 14–27)

      Antonio Romo de Vivar Chavez, William Buchser, Per H. Basse, Xiaoyan Liang, Leonard J. Appleman, Jodi K. Maranchie, Herbert Zeh, Michael E. de Vera and Michael T. Lotze

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05160.x

    3. Perspective on Potential Clinical Applications of Recombinant Human Interleukin-7 (pages 28–38)

      Claude Sportès, Ronald E. Gress and Crystal L. Mackall

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05075.x

    4. Immune Modulation with Interleukin-21 (pages 39–46)

      Neela S. Bhave and William E. Carson III

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05071.x

    5. Clinical and Immunologic Basis of Interferon Therapy in Melanoma (pages 47–57)

      Ahmad A. Tarhini and John M. Kirkwood

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05073.x

      Corrected by:

      Corrigendum for Ann. N.Y. Acad. Sci. 2009. 1182: 47–57

      Vol. 1267, Issue 1, 117, Version of Record online: 6 SEP 2012

    6. Heterogeneous, Longitudinally Stable Molecular Signatures in Response to Interferon-β (pages 58–68)

      M. R. Sandhya Rani, Yaomin Xu, Jar-chi Lee, Jennifer Shrock, Anupama Josyula, Joerg Schlaak, Swathi Chakraborthy, Nie Ja, Richard M. Ransohoff and Richard A. Rudick

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05068.x

    7. Clinical Use of Interferon-γ (pages 69–79)

      Catriona H.T. Miller, Stephen G. Maher and Howard A. Young

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05069.x

    8. Interferon Lambda as a Potential New Therapeutic for Hepatitis C (pages 80–87)

      Dennis M. Miller, Kevin M. Klucher, Jeremy A. Freeman, Diana F. Hausman, David Fontana and Doug E. Williams

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05241.x

    9. Cytokines as Targets for Anti-inflammatory Agents (pages 88–96)

      Larry W. Moreland

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05072.x

    10. Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases (pages 97–110)

      Michael Elliott, Jacqueline Benson, Marion Blank, Carrie Brodmerkel, Daniel Baker, Kristin Ruley Sharples and Philippe Szapary

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05070.x

    11. Rilonacept—CAPS and Beyond : A Scientific Journey (pages 124–134)

      Neil Stahl, Allen Radin and Scott Mellis

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05074.x

    12. Actobiotics™ as a Novel Method for Cytokine Delivery : The Interleukin-10 Case (pages 135–145)

      Lothar Steidler, Pieter Rottiers and Bernard Coulie

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05067.x

    13. Hurdles and Leaps for Protein Therapeutics : Cytokines and Inflammation (pages 146–160)

      Steven Kozlowski, Barry Cherney and Raymond P. Donnelly

      Version of Record online: 10 DEC 2009 | DOI: 10.1111/j.1749-6632.2009.05158.x

SEARCH

SEARCH BY CITATION